• 关于我们
  • 律师
  • 执业领域
    • 行业
        • 技术、媒体和通信 (TMC)
        • 国际私人财富
        • 房地产、基础设施和能源
        • 生命科学和医疗保健
        • 航空航天与国防
        • 自动化
        • 商业和专业服务
        • 化学制品
        • 消费与零售
        • 金融机构和保险
        • 酒店与休闲
        • 物流与运输
        • 制造业与工业
        • 公共服务和教育
    • 法律服务
        • Artificial intelligence
        • 银行与金融
        • 品牌和广告
        • 商业和消费者合同
        • 竞争、欧盟与贸易
        • 版权和媒体
        • 公司犯罪与合规
        • 国际企业并购与资本市场
        • 数据和网络
        • 纠纷和调查
        • 就业、养老金和流动性
        • 环境规划与监管
        • 环境、社会和公司治理 (ESG)
        • 信息技术
        • Multi-service
        • 专利与创新
        • 私人客户
        • 私募股权
        • 项目、能源和基础设施
        • 房地产与建筑
        • Regulation
        • 重组和破产
        • 税务
        • 风险投资
  • 法域
    • 欧洲
        • 位置
        • 奥地利
        • 比利时
        • 捷克共和国
        • 法国
        • 德国
        • 匈牙利
        • Italy
        • 荷兰
        • 波兰
        • Portugal
        • 爱尔兰共和国
        • 斯洛伐克
        • Spain
        • 英国
        • 乌克兰
          团体
        • CEE Turkish Desk
        • 法国德国团队
        • 办公室
    • 中东和非洲
        • 位置
        • 中东
        • 阿联酋
          团体
        • 非洲团队
        • 以色列团队
        • 办公室
    • 美洲
        • 位置
        • Latin America
        • 美国
          团体
        • 巴西团队
        • 办公室
    • 亚洲
        • 位置
        • 亚洲
        • 中国
        • 韩国
          团体
        • 印度团队
        • 日本团队
        • 办公室
  • 新闻和观点
    • 观点
        • 热点话题
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: 技术、知识产权和媒体法
        • Podcasts
        • Synapse
        • 浏览所有观点
    • 活动
        • 亲自
        • 在线的
        • Browse All Events
    • 新闻
        • 媒体中心
        • 工作亮点
        • 律所新闻
        • 查看全部
  • 职业发展
  • ZH
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Carlemi Calitz
Dr. Carlemi Calitz
Dr. Carlemi Calitz

Dr. Carlemi Calitz

UPC 法务官

  • 埃因霍温 荷兰
+31 88 0243 001
vCard
发送电子邮件给我 Call me

Carlemi is a UPC legal officer and patent advisor  of the Intellectual Property practice group.

She brings a uniquely multidisciplinary perspective to the Patents and Innovation team, combining over a decade of cutting-edge scientific research with a growing legal expertise. As a UPC Legal Officer with a focus on patent advisory, she draws on her extensive background in pharmaceutics, biochemistry, and advanced biomimetic modeling to support clients at the intersection of science, technology, and intellectual property.

With 27 peer-reviewed publications and experience in managing EU-funded innovation projects, she is adept at navigating complex scientific and regulatory landscapes—an asset in evaluating patentability, supporting IP strategy, and communicating effectively with inventors and examiners.

专长

执业领域和服务团队

专利与创新

行业

酒店与休闲

CV

Since 2025 UPC Legal Officer, Taylor Wessing
2021-2025 Postdoctoral Research Fellow GUTVIBRATIONS consortium, Amsterdam UMC
2018-2021 Postdoctoral Research Fellow, Uppsala University, Sweden
2018-2021 Postdoctoral Research Fellow, North west University, South Africa
2017 PhD Pharmaceutics, North west University
2014 MSc Pharmaceutics, North-west University
2011 Hons. BSc Biochemistry and Physiology, North-west University
2010 BSc Biochemistry and Physiology, North-west University

职业发展

Since 2025 UPC Legal Officer, Taylor Wessing
2021-2025 Postdoctoral Research Fellow GUTVIBRATIONS consortium, Amsterdam UMC
2018-2021 Postdoctoral Research Fellow, Uppsala University, Sweden
2018-2021 Postdoctoral Research Fellow, North west University, South Africa

教育

2017 PhD Pharmaceutics, North west University
2014 MSc Pharmaceutics, North-west University
2011 Hons. BSc Biochemistry and Physiology, North-west University
2010 BSc Biochemistry and Physiology, North-west University

Publications

  • Effect of antivirals on clinical and lab-adapted human cytomegalovirus strains using induced Pluripotent Stem Cell-derived human neural models. 2025. L Mulder, R Vieira da Sá, J Korsten, E Freeze, G Koen, R Molenkamp, J Van Kampen, M Cornelissen, F Zorgdrager, KC Wolthers, D Pajkrt, A Sridhar and C Calitz. Submitted to Antiviral Research. 
  • Towards personalized medicine: the effect of treatment of chronic enterovirus diarrhea in an immunocompromised patient and the correlation with in vitro models. 2024. G Moreni, C Calitz, G Koen, H van Eijk, N Johannesson, J De Ruijter, K S M Benschop, J Cremer, D Pajkrt, A Sridhar, E J Peters, and K C Wolthers. Submitted to Open Forum Infectious Diseases (Under review) 
  • A Human Biomimetic Intestinal Mucosa Model to Study Gastrointestinal Development and Disease. 2024. A Dei*, C Calitz*, J Korsten, N Johannesson, E Freeze, A Eaves, S Louis, R.K. Conder, W Chang, D Pajkrt, K.C. Wolthers, A Sridhar, S Simmini. Submitted to Nature Communications. https://doi.org/10.1101/2024.08.20.608742 *Shared first authorship 
  • Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease. 2024. P Capendale, I García-Rodríguez, AT Ambikan, L Mulder, J Depla, E Freeze, G Koen, C Calitz, V Sood, R Vieira de Sá, U Neogi, D Pajkrt, A Sridhar and K Wolthers. Nature Communications 15(1):2532. 10.1038/s41467-024-46634-9. 
  • The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants. 2024. Ianevski A, Frøysa, IT, Lysvand, H, Calitz, C, Smura, T, Schjelderup Nilsen, H.-J, Høyer, E, Afset, JE, Sridhar, A, Wolthers, KC, Zusinaite, E, Tenson, T, Kurg, R, Oksenych, V, Galabov, AS, Stoyanova, A, Bjørås, M and Kainov, DE. Antiviral Research.  https://doi.org/10.1016/j.antiviral.2024.105842  
  • Assessment of The Broad-Spectrum Host Targeting Antiviral Efficacy of Halofuginone Hydrobromide in Human Airway, Intestinal and Brain Organoid Models. 2024. I García-Rodríguez, G Moreni, P.E Capendale, I Aknouch, L Mulder, R Vieira de Sá, N Johannesson, E Freeze, H van Eijk, G Koen, K.C Wolthers, D Pajkrt, A Sridhar and C Calitz Antiviral Research https://doi.org/10.1016/j.antiviral.2024.105798 *Shared last authorship 
  • Non-Polio Enterovirus C Replicate in Both Airway and Intestine Organotypic Cultures. 2023 
    G Moreni, H van Eijk, G Koen, N Johannesson, C Calitz, K Benschop, J Cremer, D Pajkrt, A Sridhar and K Wolthers Viruses 15(9):1823 
  • Amino acid variation at VP1-145 of enterovirus A71 determines the viral infectivity and receptor usage in a primary human intestinal model. 2023. I Aknouch, I García-Rodríguez, F.P Giugliano, C Calitz, G Koen, H van Eijk, N Johannessson, S Rebers, L Brouwer, V Muncan, KJ Stittelaar, D Pajkrt, K.C Wolthers and A Sridhar Frontiers in Microbiology 14:1045587 
  • Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma. 2023. C Calitz, J Rosenquist, O Degerstedt, J Khaled, M Kopsida, M Fryknäs, H Lennernäs, A Samanta, F Heindryckx. Scientific Reports 13(1):748 
  • Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model. 2022. Aknouch, I., Sridhar, A., Freeze, E., Giugliano, F.P., van Keulen, B.J., Romijn, M., Calitz, C., García-Rodríguez, I., Mulder,L., Wildenberg, M.E., Muncan, V., van Gils, M.J., van Goudoever, J.B., Stittelaar, K.J., Wolthers, K.C and Pajkrt, D. Life science alliance., 5(12): e202201432 
  • Effect of liver stiffness on hepatocellular carcinoma phenotype in a biometric 3D model. 2022.  C Calitz, J Khaled, J Rosenquist, M Kopsida, O Degerstedt, H Lennernas, M Fryknäs, A Samanta and F Heindryckx. Journal of Hepatology., 77:s368 
     
    Bridging the gap between emerging models and humans by learning from polio animal studies: A systematic review. 2022.  G Moreni, I Aknouch, M Ras, L Brouwer, R Spijker, C Calitz, KJ Stittelaar, A Sridhar, KC Wolthers, D Pajkrt. Clinical and Translational Discovery., 2(2):e42 
  • In vitro cell toxicity and intracellular uptake of doxorubicin exposed as a solution or liposomes: Implications for treatment of hepatocellular carcinoma. 2021. F Kullenberg, O Degerstedt, C Calitz, N Pavlović, D Balgoma, J Gråsjö, E Sjögren, M Hedeland, F Heindryckx, H Lennernäs. Cells., 10(7):1717 
  • Anthracyclins increase PUFAs: potential implications in ER stress and cell death. 2021. 
    D Balgoma, F Kullenberg, C Calitz, M Kopsida, F Heindryckx, H Lennernäs, M Hedeland. Cells., 10(5):1163
  • Clinostat 3D cell culture – protocols for the preparation and functional analysis of highly reproducible, large, uniform spheroids and organoids. 2021. K Wrzesinski, H Sedighi-Frandsen, C Calitz, C Gouws, B Korzeniowska, SJ. Fey.  Next Generation Culture Platforms for Reliable In Vitro Models: Methods and Protocols, Chapter 2: 17-62 
  • Anticancer Potential of Sutherlandia frutescens and Xysmalobium undulatum in LS180 Colorectal Cancer Mini-Tumors. 2021. C Gouws, T Smit, C Willers, H Svitina, C Calitz, K Wrzesinski. Molecules 26(3):605 
  • Inhibiting endoplasmic reticulum stress decreases tumor burden in a mouse model for hepatocellular carcinoma. 2020. N Pavlovic, C Calitz, K Thanapirom, G Mazza, K Rombouts, P Gerwins, F Heindryckx. eLife, 9, e55865 
  • A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D. 2020. C Calitz, N Pavlovic, J Rosenquist, C Zagami, A Samanta, F Heindryckx. J. Vis. Exp. (162), e61606 
  • Characterization of an alginate encapsulated LS180 spheroid model for anti-colorectal cancer compound screening. 2020. T Smit, C Calitz, C Willers, H Svitina, J Hamman, SJ Fey, C Gouws, K Wrzesinski. ACS Medicinal Chemistry Letters 11 (5), 1014-1021 
  • Fibrin fragment E potentiates TGF-β-induced myofibroblast activation and recruitment. 2020. PÖ Fuchs, C Calitz, N Pavlović, F Binet, SMØ Solbak, UH Danielson, J Kreuger, F Heindryckx, P Gerwins. Cellular Signalling, 109661
  • A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model. 2019.  C Calitz, JH Hamman, SJ Fey, AM Viljoen, C Gouws, K Wrzesinski. Journal of Ethnopharmacology 239, 111897  
  • Toxicity and anti-prolific properties of Xysmalobium undulatum water extract during short-term exposure to two-dimensional and three-dimensional spheroid cell. 2018. C Calitz, JH Hamman, AM Viljoen, SJ Fey, K Wrzesinski, C Gouws Toxicology mechanisms and methods 28 (9), 641-652  
  • Recent Advances in Three-Dimensional Cell Culturing to Assess Liver Function and Dysfunction: From a Drug Biotransformation and Toxicity Perspective. 2018. C Calitz, JH Hamman, SJ Fey, K Wrzesinski, C Gouws Toxicology Mechanisms and Methods, 1-17  
  • Cell-free DNA in a three-dimensional spheroid cell culture model: A preliminary study. 2017.  
    C Calitz*, J Aucamp*, AJ Bronkhorst, K Wrzesinski, S Hamman, C Gouws. The international journal of biochemistry & cell biology 89, 182-192 *Shared first authorship 
  • Herb-drug pharmacokinetic interactions: transport and metabolism of indinavir in the presence of selected herbal products. 2015. C Calitz, C Gouws, J Viljoen, J Steenekamp, L Wiesner, E Abay. Molecules 20 (12), 22113-22127  
  • Herbal hepatotoxicity: current status, examples, and challenges. 2015. C Calitz, L Du Plessis, C Gouws, D Steyn, J Steenekamp, C Muller. Expert opinion on drug metabolism & toxicology 11 (10), 1551-1565  
  • Impact of traditional African medicine on drug metabolism and transport. 2014. C Calitz, JH Steenekamp, JD Steyn, C Gouws, JM Viljoen, JH Hamman Expert opinion on drug metabolism & toxicology 10 (7), 991-1003   
     

会员资格和附属关系

The Pharmaceutical society of South Africa PSSA

语言

English Afrikaans Dutch

Related news & insights

专利与创新

Episode 9 - Using expert evidence in the UPC

2025年5月19日

作者

点击此处了解更多
品牌与广告业

UK to maintain current exhaustion of rights regime

2025年5月15日
Quick read

作者 Louise Popple

点击此处了解更多
/Taylor Wessing/Images/Search Result Thumbnails/Insights News and Event/Locations/France/AdobeStock_44592598 place Vendome
专利与创新

Taylor Wessing strengthens pan-European patent law offering with new team in Paris

2025年5月7日

作者

点击此处了解更多
专利与创新

Episode 8 - Confidentiality protection and transparency in the UPC

2025年5月1日

作者

点击此处了解更多
酒店与休闲

Updated post-market surveillance (PMS) rules for medical devices in the UK: differences from the EU regulations

2025年5月1日
In-depth analysis

作者 Alison Dennis 以及 Alice Matthews

点击此处了解更多
UPC

The UPC: The new forum defines its jurisdictional boundaries

2025年4月30日
In-depth analysis

作者

点击此处了解更多
专利与创新

Episode 7 - Obtaining documentary evidence in the UPC - a look at Rule 190 of the Rules of Procedure

2025年4月15日

作者

点击此处了解更多
Careers

Announcing 20 senior promotions for 2025, including 10 to partnership

2025年4月9日

作者 Shane Gleghorn 以及 Dr. Oliver Bertram

点击此处了解更多
专利与创新

Episode 6 - Injunctions and proportionality in the UPC

2025年3月31日

作者

点击此处了解更多
intellectual property freedom of expression
技术、媒体与通信 (TMC)

Freedom of expression and the right to reputation: finding the right balance

2025年3月27日
Briefing

作者 Lucas de Groot 以及 Naomi Kannekens

点击此处了解更多
View all insights

相关人员

荷兰
Wim Maas

Dr. Wim Maas

合伙人

阿姆斯特丹
埃因霍温
+31 6 3175 2962
发送电子邮件给我
查看个人资料
Geert Theuws

Geert Theuws

法律顾问

埃因霍温
+31 88 02 43 197
发送电子邮件给我
查看个人资料
David Mulder

David Mulder

法律顾问

阿姆斯特丹
+31 88 02 43 019
发送电子邮件给我
查看个人资料
Yingyi Liu

Yingyi Liu

UPC 法务官

阿姆斯特丹
埃因霍温
+31 88 02 43 086
发送电子邮件给我
查看个人资料
Paula Terzini Leite

Paula Terzini Leite

UPC 法务官

埃因霍温
+31 88 02 43 282
发送电子邮件给我
查看个人资料
Full team

与我会面:

查看所有活动
订阅
  • 关于我们
  • Campaigns and online tools
  • 新闻
  • 律师
  • 执业领域
  • 法域
  • 新闻和观点
  • 活动
  • 媒体中心
  • 联系方式
  • 职业发展
  • 校友
  • 数据保护和隐私政策
  • 网络隐私和 Cookie 政策
  • 监管
  • 有关费用的监管信息
  • 客户投诉程序
  • 使用条款
  • 反奴役宣言
  • 环境
  • 垃圾电子邮件

© Taylor Wessing